Fig. 3From: Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fractionPlasma levels of renin activity and aldosterone at baseline and after 30 and 60 days of S/V treatment. Means ± se; **p < 0.01 versus baselineBack to article page